AmerisourceBergen Corporation (Holding Co) (ABC) : 11 analysts are covering AmerisourceBergen Corporation (Holding Co) (ABC) and their average rating on the stock is 2.82, which is read as a Hold. 1 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 10 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
AmerisourceBergen Corporation (Holding Co) (ABC) : The highest level AmerisourceBergen Corporation (Holding Co) (ABC) is projected to reach is $105 for the short term and the lowest estimate is at $77. The consolidated price target from 10 rating analysts who initiate coverage on the stock is $90.5 and the possibility the share price can swing is $7.32.
Company shares have received an average consensus rating of Hold for the current week AmerisourceBergen Corporation (Holding Co) (NYSE:ABC): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $87.97 and $87.47 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $89.05. The buying momentum continued till the end and the stock did not give up its gains. It closed at $88.95, notching a gain of 1.19% for the day. The total traded volume was 1,669,302 . The stock had closed at $87.90 on the previous day.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Executive Vice President) of Amerisourcebergen Corp, Danilewitz Dale had sold 1,586 shares worth of $137,665 in a transaction dated March 1, 2016. In this transaction, 1,586 shares were sold at $86.8 per share.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.